Atherosclerotic Cardiovascular Disease trials recruiting in Idaho

Fewer than 3 recruiting trials found.

All Atherosclerotic Cardiovascular Disease trials nationally

1

Recruiting in Idaho

1

Cities with sites

Cities in Idaho

Meridian 1

Recruiting trials in Idaho

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female) · Idaho: Meridian

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.